Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 92

1.

Transient repolarization instability following the initiation of cardiac resynchronization therapy.

Braunschweig F, Pfizenmayer H, Rubulis A, Schoels W, Linde C, Bergfeldt L.

Europace. 2011 Sep;13(9):1327-34. doi: 10.1093/europace/eur103.

2.

Dabigatran versus warfarin in patients with atrial fibrillation.

Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L; RE-LY Steering Committee and Investigators..

N Engl J Med. 2009 Sep 17;361(12):1139-51. doi: 10.1056/NEJMoa0905561. Erratum in: N Engl J Med. 2010 Nov 4;363(19):1877.

3.

Green tea flavonoid epigallocatechin-3-gallate (EGCG) inhibits cardiac hERG potassium channels.

Kelemen K, Kiesecker C, Zitron E, Bauer A, Scholz E, Bloehs R, Thomas D, Greten J, Remppis A, Schoels W, Katus HA, Karle CA.

Biochem Biophys Res Commun. 2007 Dec 21;364(3):429-35.

PMID:
17961513
4.

Optimizing implantable cardioverter-defibrillator treatment of rapid ventricular tachycardia: antitachycardia pacing therapy during charging.

Schoels W, Steinhaus D, Johnson WB, O'hara G, Schwab JO, Jenniskens I, Degroot PJ, Tang F, Helmling E; EnTrust Clinical Study Investigators..

Heart Rhythm. 2007 Jul;4(7):879-85.

PMID:
17599671
5.

Indications for predismissal testing with arrhythmia-induction in patients receiving an implantable cardioverter defibrillator.

Christ G, Becker R, Voss F, Kelemen K, Senges-Becker J, Hauck M, Schoels W, Bald I, Katus H, Bauer A.

Clin Res Cardiol. 2007 Sep;96(9):613-20.

PMID:
17593312
6.

Cardiac-specific activation of Cre expression at late fetal development.

Opherk JP, Yampolsky P, Hardt SE, Schoels W, Katus HA, Koenen M, Zehelein J.

Biochem Biophys Res Commun. 2007 Jul 27;359(2):209-13.

PMID:
17540338
7.

Prevention of inappropriate shocks in ICD recipients: a review of 10,000 tachycardia episodes.

Anselme F, Mletzko R, Bowes R, Mabo P, Sadoul N, Schoels W, Seidl K, Schwab J, Iscolo N, Nitzsché R.

Pacing Clin Electrophysiol. 2007 Jan;30 Suppl 1:S128-33. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1424.

PMID:
17302688
8.

Role of KATP channels in repetitive induction of ventricular fibrillation.

Bauer A, Becker R, Dreyhaupt J, Voss F, Kraft P, Kelemen K, Senges-Becker JC, Katus HA, Schoels W.

Europace. 2007 Mar;9(3):154-61.

9.

Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.

Klingenberg R, Zugck C, Becker R, Schellberg D, Heinze G, Kell R, Remppis A, Schoels W, Katus HA, Dengler TJ.

Heart. 2006 Sep;92(9):1323-4. No abstract available.

10.

Brief antecedent anoxia preserves mitochondrial function after sustained undersupply: a subcellular correlate to ischemic preconditioning?

Vetter SY, Elsässer A, Tutdibi O, Lang S, Schoels W, Pott A, Ackermann C, Reinhard C, Wieland F, Katus HA, Kübler W, Vogt AM.

Mol Cell Biochem. 2006 Apr;285(1-2):191-6.

PMID:
16477372
11.

Regulation of cardiac inwardly rectifying potassium current IK1 and Kir2.x channels by endothelin-1.

Kiesecker C, Zitron E, Scherer D, Lueck S, Bloehs R, Scholz EP, Pirot M, Kathöfer S, Thomas D, Kreye VA, Kiehn J, Borst MM, Katus HA, Schoels W, Karle CA.

J Mol Med (Berl). 2006 Jan;84(1):46-56.

PMID:
16258766
12.

Myocardial energy metabolism in ischemic preconditioning and cardioplegia: a metabolic control analysis.

Vogt AM, Elsässer A, Pott-Beckert A, Ackermann C, Vetter SY, Yildiz M, Schoels W, Fell DA, Katus HA, Kübler W.

Mol Cell Biochem. 2005 Oct;278(1-2):223-32.

PMID:
16180108
14.

Inhibition of cardiac HERG channels by grapefruit flavonoid naringenin: implications for the influence of dietary compounds on cardiac repolarisation.

Scholz EP, Zitron E, Kiesecker C, Lück S, Thomas D, Kathöfer S, Kreye VA, Katus HA, Kiehn J, Schoels W, Karle CA.

Naunyn Schmiedebergs Arch Pharmacol. 2005 Jun;371(6):516-25.

PMID:
16007460
15.

Regional differences in the dynamics of refractoriness in intact and hypertrophied in situ canine hearts.

Voss F, Schoels W, Lue J, Bauer A, Katus HA, Becker R.

Basic Res Cardiol. 2005 Sep;100(5):433-8.

PMID:
15965582
16.

Dominant-negative I(Ks) suppression by KCNQ1-deltaF339 potassium channels linked to Romano-Ward syndrome.

Thomas D, Wimmer AB, Karle CA, Licka M, Alter M, Khalil M, Ulmer HE, Kathöfer S, Kiehn J, Katus HA, Schoels W, Koenen M, Zehelein J.

Cardiovasc Res. 2005 Aug 15;67(3):487-97.

17.

What is the "optimal" follow-up schedule for ICD patients?

Senges-Becker JC, Klostermann M, Becker R, Bauer A, Siegler KE, Katus HA, Schoels W.

Europace. 2005 Jul;7(4):319-26.

18.

The new selective I(Ks)-blocking agent HMR 1556 restores sinus rhythm and prevents heart failure in pigs with persistent atrial fibrillation.

Bauer A, Koch M, Kraft P, Becker R, Kelemen K, Voss F, Senges JC, Gerlach U, Katus HA, Schoels W.

Basic Res Cardiol. 2005 May;100(3):270-8.

PMID:
15795798
19.

QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids.

Zitron E, Scholz E, Owen RW, Lück S, Kiesecker C, Thomas D, Kathöfer S, Niroomand F, Kiehn J, Kreye VA, Katus HA, Schoels W, Karle CA.

Circulation. 2005 Feb 22;111(7):835-8.

20.

Class Ia anti-arrhythmic drug ajmaline blocks HERG potassium channels: mode of action.

Kiesecker C, Zitron E, Lück S, Bloehs R, Scholz EP, Kathöfer S, Thomas D, Kreye VA, Katus HA, Schoels W, Karle CA, Kiehn J.

Naunyn Schmiedebergs Arch Pharmacol. 2004 Dec;370(6):423-35.

PMID:
15599706
Items per page

Supplemental Content

Loading ...
Support Center